News, musings and commentary on pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525-3955
Monday, March 28, 2011
Key Case on Daubert and Admissibility of Expert Evidence
Image by Kevandy via Flickr
On the heels of the SCOTUS opinion in Zicam is this opinion, a 1st Circuit Opinion. Worth a read if you litigate anywhere in the USDCT: